Divi's Laboratories Management
Management criteria checks 2/4
Divi's Laboratories' CEO is Kiran Divi, appointed in Jan 2020, has a tenure of 5.75 years. total yearly compensation is ₹307.70M, comprised of 3% salary and 97% bonuses, including company stock and options. directly owns 20.34% of the company’s shares, worth ₹316.76B. The average tenure of the management team and the board of directors is 5.8 years and 8.3 years respectively.
Key information
Kiran Divi
Chief executive officer
₹307.7m
Total compensation
CEO salary percentage | 2.99% |
CEO tenure | 5.8yrs |
CEO ownership | 20.3% |
Management average tenure | 5.8yrs |
Board average tenure | 8.3yrs |
Recent management updates
Recent updates
Divi's Laboratories Limited's (NSE:DIVISLAB) Share Price Could Signal Some Risk
Sep 06Divi's Laboratories Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Aug 10Most Shareholders Will Probably Agree With Divi's Laboratories Limited's (NSE:DIVISLAB) CEO Compensation
Aug 05Here's What Analysts Are Forecasting For Divi's Laboratories Limited (NSE:DIVISLAB) After Its Yearly Results
Jul 17Divi's Laboratories Limited (NSE:DIVISLAB) Investors Are Less Pessimistic Than Expected
Apr 10Divi's Laboratories Limited's (NSE:DIVISLAB) Shareholders Might Be Looking For Exit
Dec 25Tactical Expansions And Innovation Could Offset Generic Pricing Pressures And Boost Profitability
Strategic investments in peptide synthesis and greenfield expansion enhance future revenue potential through capacity and product line growth.CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Jun 30 2025 | n/a | n/a | ₹23b |
Mar 31 2025 | ₹308m | ₹9m | ₹22b |
Dec 31 2024 | n/a | n/a | ₹21b |
Sep 30 2024 | n/a | n/a | ₹18b |
Jun 30 2024 | n/a | n/a | ₹17b |
Mar 31 2024 | ₹228m | ₹9m | ₹16b |
Dec 31 2023 | n/a | n/a | ₹14b |
Sep 30 2023 | n/a | n/a | ₹13b |
Jun 30 2023 | n/a | n/a | ₹15b |
Mar 31 2023 | ₹248m | ₹9m | ₹18b |
Dec 31 2022 | n/a | n/a | ₹24b |
Sep 30 2022 | n/a | n/a | ₹30b |
Jun 30 2022 | n/a | n/a | ₹31b |
Mar 31 2022 | ₹377m | ₹5m | ₹30b |
Dec 31 2021 | n/a | n/a | ₹26b |
Sep 30 2021 | n/a | n/a | ₹21b |
Jun 30 2021 | n/a | n/a | ₹20b |
Mar 31 2021 | ₹282m | ₹10m | ₹20b |
Dec 31 2020 | n/a | n/a | ₹19b |
Sep 30 2020 | n/a | n/a | ₹18b |
Jun 30 2020 | n/a | n/a | ₹16b |
Mar 31 2020 | ₹184m | ₹8m | ₹14b |
Dec 31 2019 | n/a | n/a | ₹13b |
Sep 30 2019 | n/a | n/a | ₹13b |
Jun 30 2019 | n/a | n/a | ₹14b |
Mar 31 2019 | ₹202m | ₹8m | ₹14b |
Compensation vs Market: Kiran's total compensation ($USD3.47M) is above average for companies of similar size in the Indian market ($USD1.17M).
Compensation vs Earnings: Kiran's compensation has increased by more than 20% in the past year.
CEO
Kiran Divi (49 yo)
Dr. Kiran Satchandra Divi has been the Chief Executive Officer of Divi's Laboratories Limited since January 4, 2020. Dr. Divi has been an Whole-time Director at Divi's Laboratories Limited since August 10,...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO & Whole-Time Director | 5.8yrs | ₹307.70m | 20.34% ₹ 316.8b | |
Executive Director | 31yrs | ₹451.80m | no data | |
MD & Executive Director | no data | ₹881.50m | 2.85% ₹ 44.4b | |
Whole-Time Director (Manufacturing) | 1.7yrs | ₹31.10m | 0.023% ₹ 351.9m | |
Whole-time Director | 4.3yrs | ₹307.00m | no data | |
Chief Information Officer | less than a year | no data | no data | |
Company Secretary & Compliance Officer | 6.3yrs | ₹3.80m | no data | |
Vice President of Sales | no data | ₹28.70m | no data | |
Global Quality Head | no data | ₹14.00m | no data | |
Chief Technologist - PDSC | no data | ₹23.60m | 0.0052% ₹ 80.4m | |
Chief Technologist - PDSC | no data | ₹23.60m | 0.014% ₹ 219.7m | |
Vice President of Procurement | 16.4yrs | ₹21.50m | no data |
Experienced Management: DIVISLAB's management team is seasoned and experienced (5.8 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO & Whole-Time Director | 24.2yrs | ₹307.70m | 20.34% ₹ 316.8b | |
Executive Director | 31yrs | ₹451.80m | no data | |
MD & Executive Director | 35yrs | ₹881.50m | 2.85% ₹ 44.4b | |
Whole-Time Director (Manufacturing) | 1.7yrs | ₹31.10m | 0.023% ₹ 351.9m | |
Whole-time Director | 8.3yrs | ₹307.00m | no data | |
Independent Non-Executive Chairman | 8.3yrs | ₹3.50m | no data | |
Non-Executive Independent Director | 8.3yrs | ₹3.20m | no data | |
Non-Executive Independent Director | 6.6yrs | ₹2.70m | no data | |
Non-Executive Independent Director | 5.8yrs | ₹3.10m | no data | |
Independent Director | 1.4yrs | ₹2.40m | no data |
Experienced Board: DIVISLAB's board of directors are considered experienced (8.3 years average tenure).
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/10/03 00:40 |
End of Day Share Price | 2025/10/03 00:00 |
Earnings | 2025/06/30 |
Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Divi's Laboratories Limited is covered by 57 analysts. 29 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Ashwin Mehta | Ambit Capital |
Nitin Bhasin | Ambit Capital |
Prashant Nair | Ambit Capital |